100 related articles for article (PubMed ID: 38719736)
1. Multidisciplinary meeting review in nonsmall cell lung cancer: a systematic review and meta-analysis.
Stirling RG; Harrison A; Huang J; Lee V; Taverner J; Barnes H
Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 38719736
[TBL] [Abstract][Full Text] [Related]
2. Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort study.
Lin T; Pham J; Paul E; Conron M; Wright G; Ball D; Mitchell P; Atkin N; Brand M; Zalcberg J; Stirling RG
Lung Cancer; 2022 Jan; 163():69-76. PubMed ID: 34923204
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Do multidisciplinary team meetings make a difference in the management of lung cancer?
Boxer MM; Vinod SK; Shafiq J; Duggan KJ
Cancer; 2011 Nov; 117(22):5112-20. PubMed ID: 21523766
[TBL] [Abstract][Full Text] [Related]
6. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis.
Armoiry X; Tsertsvadze A; Connock M; Royle P; Melendez-Torres GJ; Souquet PJ; Clarke A
PLoS One; 2018; 13(7):e0199575. PubMed ID: 30044785
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: A systematic review and meta-analysis.
Dawe DE; Christiansen D; Swaminath A; Ellis PM; Rothney J; Rabbani R; Abou-Setta AM; Zarychanski R; Mahmud SM
Lung Cancer; 2016 Sep; 99():180-5. PubMed ID: 27565937
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary lung cancer meetings: improving the practice of radiation oncology and facing future challenges.
Campbell BA; Ball D; Mornex F
Respirology; 2015 Feb; 20(2):192-8. PubMed ID: 25581058
[TBL] [Abstract][Full Text] [Related]
10. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes for cancer patients discussed and not discussed at a multidisciplinary meeting.
Rogers MJ; Matheson L; Garrard B; Maher B; Cowdery S; Luo W; Reed M; Riches S; Pitson G; Ashley DM
Public Health; 2017 Aug; 149():74-80. PubMed ID: 28575751
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
13. Impacts of multidisciplinary meeting case discussion on palliative care referral and end-of-life care in lung cancer: a retrospective observational study.
Sridharan K; Paul E; Stirling RG; Li C
Intern Med J; 2021 Sep; 51(9):1450-1456. PubMed ID: 33463032
[TBL] [Abstract][Full Text] [Related]
14. Concordance of a decision algorithm and multidisciplinary team meetings for patients with liver cancer-a study protocol for a randomized controlled trial.
Ng SST; Oehring R; Ramasetti N; Roller R; Thomas P; Chen Y; Moosburner S; Winter A; Maurer MM; Auer TA; Kamali C; Pratschke J; Benzing C; Krenzien F
Trials; 2023 Sep; 24(1):577. PubMed ID: 37684688
[TBL] [Abstract][Full Text] [Related]
15. Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study.
Stone E; Rankin N; Kerr S; Fong K; Currow DC; Phillips J; Connon T; Zhang L; Shaw T
Lung Cancer; 2018 Oct; 124():199-204. PubMed ID: 30268461
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.
Yang ZY; Liu L; Mao C; Wu XY; Huang YF; Hu XF; Tang JL
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009948. PubMed ID: 25400254
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of adjuvant chemotherapy versus surgery alone in T2aN0 stage IB non-small cell lung cancer.
Zhang T; Guo Q; Zhang Y; Liu Z; Zhou S; Xu S
J Cancer Res Ther; 2018 Jan; 14(1):139-144. PubMed ID: 29516976
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer.
Hung HY; Tseng YH; Chao HS; Chiu CH; Hsu WH; Hsu HS; Wu YC; Chou TY; Chen CK; Lan KL; Chen YW; Wu YH; Chen YM
PLoS One; 2020; 15(10):e0236503. PubMed ID: 33031375
[TBL] [Abstract][Full Text] [Related]
19. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Burdett S; Pignon JP; Tierney J; Tribodet H; Stewart L; Le Pechoux C; Aupérin A; Le Chevalier T; Stephens RJ; Arriagada R; Higgins JP; Johnson DH; Van Meerbeeck J; Parmar MK; Souhami RL; Bergman B; Douillard JY; Dunant A; Endo C; Girling D; Kato H; Keller SM; Kimura H; Knuuttila A; Kodama K; Komaki R; Kris MG; Lad T; Mineo T; Piantadosi S; Rosell R; Scagliotti G; Seymour LK; Shepherd FA; Sylvester R; Tada H; Tanaka F; Torri V; Waller D; Liang Y;
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD011430. PubMed ID: 25730344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
